Unitree Robotics Q1 profit drops 52% days before IPO hearing
Synopsis
Unitree Robotics, days from its June 1 IPO hearing, revealed Q1 adjusted profit crashed 52% to 40.3 million yuan despite revenue surging 68% — a stark warning that China's humanoid robot boom is colliding with soaring costs and a brutal price war.
Key Takeaways
Unitree Robotics ' Q1 adjusted net profit fell more than 52 per cent year on year to 40.3 million yuan , down from 84.8 million yuan .
Q1 revenue rose over 68 per cent year on year to 422.8 million yuan , driven by rapid scaling.
The Shanghai Stock Exchange listing committee is scheduled to review the Star Market IPO application on June 1, 2026 .
Unitree aims to raise 4.2 billion yuan (US$618.94 million) for robot development, embodied AI models, and manufacturing.
The company warned that stalled commercial adoption of general-purpose robots could put further pressure on growth and margins.
Confirmation of the IPO hearing date triggered a buying frenzy in mainland Chinese markets among retail investors exposed to Unitree .
Unitree Robotics, one of China's most prominent humanoid robot makers, disclosed a sharp 52 per cent plunge in first-quarter adjusted net profit just days before its landmark listing hearing, exposing the gap between investor enthusiasm and financial reality in the country's fast-moving robotics sector.
The Numbers Behind the Slide
An updated regulatory filing released late on Monday, 26 May 2026 revealed that while Unitree's first-quarter revenue surged more than 68 per cent year on year to 422.8 million yuan, its adjusted net profit — stripped of non-recurring items — fell to 40.3 million yuan, down from 84.8 million yuan in the same period a year earlier. The company attributed the squeeze to a significant spike in research, development, and sales expenses, alongside a normalisation of the broader humanoid robotics hype cycle.
The Hangzhou-based company, headquartered in Zhejiang province in eastern China, also pointed to a much higher revenue base following an explosive 2025 and intensifying price competition across the sector as additional headwinds.
The IPO at Stake
The Shanghai Stock Exchange's listing committee is scheduled to review Unitree's Star Market IPO application on June 1, 2026, according to an exchange notice. The company is seeking to raise 4.2 billion yuan (approximately US$618.94 million) to fund robot body development, embodied AI model research, and expanded manufacturing facilities.
The confirmation of the hearing date triggered a buying frenzy in mainland Chinese markets on Tuesday, with retail investors aggressively chasing listed companies that carry direct exposure to Unitree, including its pre-listing shareholders and upstream component suppliers.
Why It Matters
The profit deterioration arrives at a delicate moment. Investors have poured capital into China's humanoid robotics space on the expectation of rapid commercial adoption, but Unitree's own filing now warns that if the uptake of general-purpose robots stalls — or if demand in the short-term robot leasing market weakens — growth and margins could face further pressure. The candid disclosure is a notable signal that the industry's cost structures are tightening even as revenues climb.
The competitive backdrop has grown considerably more complex, with domestic rivals and global players including Tesla's Optimus programme intensifying pressure on pricing and product differentiation.
What's Next
All eyes now turn to the Shanghai Stock Exchange listing committee's decision on June 1. A successful outcome would mark a pivotal step for Unitree and could set a valuation benchmark for the broader Chinese humanoid robotics sector. Investors and analysts will be watching closely to see whether the committee weighs the revenue growth trajectory against the margin compression when assessing the company's readiness for public markets.
Point of View
Arriving days before a high-stakes listing review, is the clearest evidence yet that the industry's hype cycle has peaked even as capital continues to flow in. Mainstream coverage celebrates the revenue surge, but the margin collapse — driven by R&D and sales cost inflation alongside a price war — mirrors patterns seen in China's EV and solar industries, where commoditisation arrived far faster than incumbents anticipated. The June 1 hearing will test whether public market gatekeepers are willing to price ambition over profitability.
NationPress
10 Jul 2026
Frequently Asked Questions
What happened to Unitree Robotics' profits in Q1 2026?
Unitree Robotics reported that its Q1 2026 adjusted net profit fell more than 52 per cent year on year to 40.3 million yuan, down from 84.8 million yuan in the same period a year earlier. The company attributed the decline to a sharp rise in research, development, and sales expenses, as well as intensifying competition.
When is the Unitree Robotics IPO hearing?
The Shanghai Stock Exchange's listing committee is scheduled to review Unitree Robotics' Star Market IPO application on June 1, 2026. The company is seeking to raise 4.2 billion yuan (approximately US$618.94 million) through the listing.
How much is Unitree Robotics raising in its IPO?
Unitree Robotics is seeking to raise 4.2 billion yuan, equivalent to approximately US$618.94 million. The funds are intended to finance robot body development, embodied AI model research, and new manufacturing facilities.
Why did Unitree Robotics' margins shrink despite revenue growth?
Unitree Robotics said the margin compression resulted from a significant spike in R&D and sales expenses, a cooling of the broader humanoid robotics hype cycle, a higher revenue base following an explosive 2025, and increasingly fierce price competition in the sector.
How does Unitree Robotics compare to Tesla Optimus in the humanoid robot space?
Unitree Robotics is among China's leading humanoid robot developers and competes in a global market that includes Tesla's Optimus programme. The intensifying rivalry has contributed to the price war that the company cited as a factor squeezing its margins in early 2026.
